Related Experiment Video
Updated: Jun 16, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
An intensive insulinotherapy mobile phone application built on artificial intelligence techniques.
Kevin Curran1, Eric Nichols, Ermai Xie
1Faculty of Computing and Engineering, University of Ulster, Northern Ireland, UK. kj.curran@ulster.ac.uk
Journal of Diabetes Science and Technology
|February 20, 2010
Summary
A new mobile app uses a neural network to help people with diabetes calculate insulin doses based on lifestyle. This intelligent system aims to improve diabetes management for users, especially children and young adults.
Area of Science:
- Biomedical Engineering
- Artificial Intelligence in Healthcare
- Mobile Health (mHealth)
Background:
- The diabetes management software market is nascent, with current solutions lacking personalization.
- Previous mobile health applications were limited by technology and device availability.
- Advancements in mobile technology now enable sophisticated, personalized health applications.
Purpose of the Study:
- To develop an intelligent, mobile device-based software for personalized diabetes management.
- To create a user-friendly interface for real-time insulin dose calculation.
- To leverage neural network technology for improved insulin therapy.
Main Methods:
- An intelligent neural network with four neurons, including glucose level input, was developed for mobile devices.
- A multipanel graphical user interface was designed for ease of use and real-time data input.
- The system calculates insulin dosage based on glucose levels, adjusting for high or low readings.
Main Results:
- A 2-week feasibility trial with six patients demonstrated the approach's value.
- The study confirmed the feasibility of remote data transmission via 3G to a central server.
- Feedback on the user interface and mobile phone usability was positive, indicating potential for future intelligent insulin pumps.
Conclusions:
- Existing software lacks personalized insulin dosing based on individual lifestyle factors.
- This novel mobile application offers a supplementary tool for healthcare professionals in managing diabetes.
- The system shows promise for assisting individuals, particularly children and young adults, in daily insulin management.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:16Non-equilibrium in the Cell
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...